NG PHARM LTD

Company Registration Number:
SC726393 (Scotland)

Unaudited statutory accounts for the year ended 31 March 2024

(Dormant)

Period of accounts

Start date: 25 March 2023

End date: 31 March 2024

NG PHARM LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

NG PHARM LTD

Company Information

for the Period Ended 31 March 2024




Registered office: Unit 9c Millennium Court
Burns Street
Glasgow
GB-SCT
G4 9SA
Company Registration Number: SC726393 (Scotland)

NG PHARM LTD

Balance sheet

As at 31 March 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 4 20 10
Tangible assets: 5 7,668 5,820
Total fixed assets: 7,688 5,830
Current assets
Stocks: 10 10
Debtors: 6 0 0
Cash at bank and in hand: 1,000 1,000
Total current assets: 1,010 1,010
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 7 ( 200 ) ( 200 )
Net current assets (liabilities): 810 810
Total assets less current liabilities: 8,498 6,640
Creditors: amounts falling due after more than one year: 8 ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): 8,498 6,640

The notes form part of these financial statements

NG PHARM LTD

Balance sheet continued

As at 31 March 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 8,498 6,640
Revaluation reserve: 0 0
Profit and loss account: 0 0
Shareholders funds: 8,498 6,640

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31 March 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 23 April 2024
And Signed On Behalf Of The Board By:

Name: Gavin Tsang
Status: Director

The notes form part of these financial statements

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 2 2

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Intangible assets

Other Total
Cost £ £
At 25 March 2023 10 10
Additions - -
Disposals - -
Revaluations - -
Transfers 10 10
At 31 March 2024 20 20
Amortisation
Amortisation at 25 March 2023 0 0
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 March 2024 0 0
Net book value
Net book value at 31 March 2024 20 20
Net book value at 24 March 2023 10 10

Low value due to not tradiing

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Tangible assets

Office equipment Total
Cost £ £
At 25 March 2023 5,820 5,820
Additions - -
Disposals - -
Revaluations - -
Transfers 1,848 1,848
At 31 March 2024 7,668 7,668
Depreciation
At 25 March 2023 - -
Charge for year - -
On disposals - -
Other adjustments - -
At 31 March 2024 - -
Net book value
At 31 March 2024 7,668 7,668
At 24 March 2023 5,820 5,820

Low numbers due to no trading and rent paid

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Debtors


2024
£

2023
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

No stock as no trading

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

7.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 200 200
Accruals and deferred income 0 0
Total 200 200

penalty for not filing accounts

NG PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

8.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 0 0
Total 0 0

Low numbers due to no trading